Literature DB >> 25318872

Protection of salvianolate against atherosclerosis via regulating the inflammation in rats.

Chun Meng1, Xiao-Qing Zhuo2, Guo-Hong Xu3, Jian-Li Liu4.   

Abstract

Inflammation plays an essential role in the pathophysiology of atherosclerosis. Our study was aimed to investigate whether salvianolate, a novel water-soluble phenolic compound of Danshen, alleviates atherosclerosis via regulating the inflammation in rats. High fat diet feeding plus vitamin D3 injection was used to induce atherosclerosis in rats. Salvianolate (60, 120 or 240 mg/kg) or placebo was given to atherosclerotic rats. The plasma lipids, interleukin 6 (IL-6) and C reactive protein (CRP) were measured by ELISA. CD4+CD25+Foxp3+ cells were determined by flow cytometry. Histological changes were examined by hematoxylin and eosin staining. The results showed that the levels of plasma IL-6 and CRP were elevated in the rats fed on high fat diet, and the histological analysis demonstrated the successful establishment of atherosclerosis models. Treatment with salvianolate alleviated the atherosclerotic process and decreased the levels of plasma IL-6 and CRP. Also the number of CD4+CD25+Foxp3+ cells was increased in salvianolate-treated rats. It was concluded that salvianolate could treat atherosclerosis via modulating the inflammation at cytokine and cell levels.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318872     DOI: 10.1007/s11596-014-1331-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  32 in total

1.  The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells.

Authors:  Minoru Fujimoto; Mayumi Nakano; Fumitaka Terabe; Hirohisa Kawahata; Tomoharu Ohkawara; Yongmei Han; Barry Ripley; Satoshi Serada; Teppei Nishikawa; Akihiro Kimura; Shintaro Nomura; Tadamitsu Kishimoto; Tetsuji Naka
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

2.  Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats.

Authors:  Y Jiang; N Wei; T Lu; J Zhu; G Xu; X Liu
Journal:  Neuroscience       Date:  2010-10-27       Impact factor: 3.590

3.  Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells.

Authors:  J S Kim; A S Narula; C Jobin
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 4.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography.

Authors:  Thomas G Brott; Jonathan L Halperin; Suhny Abbara; J Michael Bacharach; John D Barr; Ruth L Bush; Christopher U Cates; Mark A Creager; Susan B Fowler; Gary Friday; Vicki S Hertzberg; E Bruce McIff; Wesley S Moore; Peter D Panagos; Thomas S Riles; Robert H Rosenwasser; Allen J Taylor; Alice K Jacobs; Sidney C Smith; Jeffery L Anderson; Cynthia D Adams; Nancy Albert; Christopher E Buller; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Sharon Ann Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; E Magnus Ohman; Richard L Page; Barbara Riegel; William G Stevenson; Lynn G Tarkington; Clyde W Yancy
Journal:  Catheter Cardiovasc Interv       Date:  2011-02-03       Impact factor: 2.692

5.  Effects of suxiao jiuxin pill (see test) on oxidative stress and inflammatory response in rats with experimental atherosclerosis.

Authors:  Chun-Shen L i; Zhu-Qiu Qu; Sha-Sha Wang; Xu-Wen Hao; Xiu-Qin Zhang; Jing Guan; Fei Han
Journal:  J Tradit Chin Med       Date:  2011-06       Impact factor: 0.848

6.  CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells.

Authors:  Shaolin He; Ming Li; Xuming Ma; Jing Lin; Dazhu Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-07       Impact factor: 8.311

Review 7.  CD4+ T cells in atherosclerosis: regulation by platelets.

Authors:  Nailin Li
Journal:  Thromb Haemost       Date:  2013-02-28       Impact factor: 5.249

8.  Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes.

Authors:  G T Liu; T M Zhang; B E Wang; Y W Wang
Journal:  Biochem Pharmacol       Date:  1992-01-22       Impact factor: 5.858

9.  Therapeutic effects of water soluble danshen extracts on atherosclerosis.

Authors:  Yoon Hee Cho; Cheol Ryong Ku; Zhen-Yu Hong; Ji Hoe Heo; Eun Hee Kim; Dong Hoon Choi; Dongkyu Kim; Ae-Jung Kim; Cheol Soon Lee; Mankil Jung; Hyun Chul Lee; Miran Seo; Eun Jig Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-16       Impact factor: 2.629

Review 10.  Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis.

Authors:  Esin Eren; Necat Yilmaz; Ozgur Aydin
Journal:  Cholesterol       Date:  2013-10-07
View more
  6 in total

1.  A Prospective Randomized Multicenter Controlled Trial on Salvianolate for Treatment of Unstable Angina Pectoris in A Chinese Elderly Population.

Authors:  Hua Cui; Xiao-Ying Li; Xue-Wen Gao; Xiang Lu; Xiu-Ping Wu; Xiao-Fei Wang; Xiang-Qing Zheng; Kui Huang; Feng Liu; Zhi Luo; Hui-Shu Yuan; Gang Sun; Jian Kong; Xiao-Hong Du; Jin Zheng; Hong-Ying Liu; Wen-Ju Zhang
Journal:  Chin J Integr Med       Date:  2019-11-28       Impact factor: 1.978

2.  The effect of Danshen extract on lipoprotein-associated phospholipase A2 levels in patients with stable angina pectoris: study protocol for a randomized controlled trial - the DOLPHIN study.

Authors:  A-Di Chen; Chun-Ling Wang; Yang Qin; Liang Tian; Li-Bin Chen; Xiao-Ming Yuan; Lin-Xiu Ma; Yu-Feng Wang; Ji-Rong Sun; Hao-Sen Wang; Neng Dai
Journal:  Trials       Date:  2017-12-20       Impact factor: 2.279

Review 3.  Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.

Authors:  Lili Wang; Rufeng Ma; Chenyue Liu; Haixia Liu; Ruyuan Zhu; Shuzhen Guo; Minke Tang; Yu Li; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

4.  The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  Yuehong Shen; Shulin Wang; Yuanyuan Liu; Ling Ge; Lili Xia; Xiaoxiao Zhang; Yuying Miao; Jianping Shen; Qian Zhou
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

5.  Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease.

Authors:  Pengxin Dong; Hao Hu; Xiaodong Guan; Carolina Oi Lam Ung; Luwen Shi; Sheng Han; Shuwen Yu
Journal:  Chin Med       Date:  2018-06-14       Impact factor: 5.455

Review 6.  Traditional chinese medicine in coronary microvascular disease.

Authors:  Zhihua Yang; Shanshan Lin; Yangxi Liu; Qiuan Ren; Zhao Ge; Ci Wang; Yingfei Bi; Xianliang Wang; Jingyuan Mao
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.